Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001532514 | SCV001748116 | pathogenic | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | MTRR: PM3:Strong, PM2, PP4:Moderate, PS3:Moderate |
Gene |
RCV001532514 | SCV001765914 | likely pathogenic | not provided | 2024-03-14 | criteria provided, single submitter | clinical testing | Observed in apparent homozygous state or with another MTRR variant in patients referred for genetic testing at GeneDx or in published literature with features suggestive of homocystinuria, cblE complementation type, but it is not known whether the variants occurred on the same (in cis) or on different (in trans) chromosomes in some cases (PMID: 22887477, 10484769); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 10484769, 22887477) |
Fulgent Genetics, |
RCV002501867 | SCV002810276 | likely pathogenic | Methylcobalamin deficiency type cblE; Neural tube defects, folate-sensitive | 2024-03-08 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003470854 | SCV004198761 | likely pathogenic | Neural tube defects, folate-sensitive | 2024-03-29 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001836441 | SCV002084993 | likely pathogenic | Methylcobalamin deficiency type cblE | 2021-03-04 | no assertion criteria provided | clinical testing |